Determining hepatitis C virus genotype distribution among high-risk groups in Iran using real-time PCR

Table 2 Distribution of hepatitis C virus genotypes among Iranian hepatitis C virus infected patients according to route of infection n (%)

High-risk group	Frequency	Undetectable	Gt1	Gt2	Gt3	Gt4	Gt1/2	Gt1/3
Addict	550	67 (12.2)	283 (51.5)	0 (0.0)	192 (34.9)	0 (0.0)	2 (0.4)	6 (1.1)
Thalassemia	38	15 (39.5)	17 (44.7)	0 (0.0)	6 (15.8)	0 (0.0)	0 (0.0)	0 (0.0)
Hemophilia	8	2 (25.0)	5 (62.5)	0 (0.0)	1 (12.5)	0 (0.0)	0 (0.0)	0 (0.0)
Kidney graft	4	1 (25.0)	2 (50)	0 (0.0)	1 (25.0)	0 (0.0)	0 (0.0)	0 (0.0)
Dialysis	6	1 (16.7)	4 (66.7)	0 (0.0)	0 (0.0)	1 (16.7)	0 (0.0)	0 (0.0)
Liver graft	3	1 (33.3)	2 (66.7)	0 (0.0)	0 (0.)	0 (0.0)	0 (0.0)	0 (0.0)
Unknown	277	64 (23.1)	140 (50.5)	3 (1.1)	67 (24.2)	3 (1.1)	0 (0.0)	0 (0.0)
Total	886	151 (17.0)	453 (51.1)	3 (0.3)	267 (30.1)	4 (0.5)	2 (0.2)	6 (0.7)

HCV: Hepatitis C virus.